The Association for Accessible Medicines (AAM) is a trade association based in Washington, D.C., representing manufacturers and distributors of generic prescription drugs and biosimilars. AAM advocates for policies that enhance access to affordable, FDA-approved generic and biosimilar medicines. Their services include lobbying, regulatory support, and public education. The target audience includes healthcare providers, patients, and industry stakeholders. AAM's unique selling proposition is its role in promoting cost-effective healthcare solutions, saving billions in healthcare costs by facilitating the use of generics and biosimilars[1][2][3].